Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Music as an Adjunct to Ketamine Therapy for Chronic Pain
for
Chronic Pain, Chronic Noncancer Pain
Location: Montreal
Sponsor: McGill University
Sex: All
Age: 18+
Code: NCT06994559
Recruiting
Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Intellia Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06128629
Phase 3, Recruiting
Impact of Resistance Training Intensity on Blood Pressure
for
Blood Pressure Management,
Location: Sherbrooke
Sponsor: Université de Sherbrooke
Sex: Female
Age: 50 - 70
Code: NCT06845514
Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for
Focal Segmental Glomerulosclerosis
Location: East Providence RI, Mineola NY, Clifton Park NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07220083
Phase 3, Recruiting
Improvement of Women's Health After Allogeneic Stem Cell Transplantation
for
GVHD, Chronic
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal
Sex: Female
Age: 18+
Code: NCT06279676
Recruiting
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
for
Neoplasms
Location: Toronto, Montreal, Philadelphia PA, San Antonio TX
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07438782
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Worcester MA, Quebec, White Plains NY, The Bronx NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
for
Neoplasms, Prostate
Location: Toronto, Montreal, Philadelphia PA, Grand Rapids MI,
Sponsor: GlaxoSmithKline
Sex: Male
Age: 18+
Code: NCT07332455
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)